TY  - GEN
AU  - Revicki,D A
TI  - Cost effectiveness of the newer atypical antipsychotics: a review of the pharmacoeconomic research evidence
SN  - 1472-4472
PY  - 2002///0122
KW  - Antipsychotic Agents
KW  - economics
KW  - Benzodiazepines
KW  - Clozapine
KW  - therapeutic use
KW  - Cost-Benefit Analysis
KW  - Dibenzothiazepines
KW  - Health Care Costs
KW  - Humans
KW  - Imidazoles
KW  - Indoles
KW  - Olanzapine
KW  - Pirenzepine
KW  - analogs & derivatives
KW  - Quetiapine Fumarate
KW  - Randomized Controlled Trials as Topic
KW  - Risperidone
N1  - Publication Type: Journal Article; Review
ER  -